About the Authors
- Emi Furukawa
-
* E-mail: furukawa@oist.jp
Affiliation Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan
- Patricia Bado
-
Affiliations D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- Gail Tripp
-
Affiliation Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan
- Paulo Mattos
-
Affiliations D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- Jeff R. Wickens
-
Affiliation Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan
- Ivanei E. Bramati
-
Affiliations D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- Brent Alsop
-
Affiliation University of Otago, Dunedin, New Zealand
- Fernanda Meireles Ferreira
-
Affiliation D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- Debora Lima
-
Affiliation D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
- Fernanda Tovar-Moll
-
Affiliations D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- Joseph A. Sergeant
-
Affiliation VU University Amsterdam, Amsterdam, The Netherlands
- Jorge Moll
-
Affiliation D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
Competing Interests
Dr. Paulo Mattos was on the speakers’ bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, and Shire in the last three years. He received travel awards to participate in scientific meetings from Janssen-Cilag, Novartis, Eli-Lilly, and Shire in 2010 through 2012. The ADHD outpatient program (Grupo de Estudos do éficit de Atenção/Institute of Psychiatry) chaired by Dr. Mattos has also received research support from Novartis and Shire. Prof. dr. J.A. Sergeant has served on the advisory boards of Lilly and Shire, and received grants from Lilly. He has also received speaker’s fees from Shire, Lilly, Janssen-Cillag, and Novartis. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: EF PB GT PM JRW IEB BA FTM JM. Performed the experiments: PB PM JM DL FTM. Analyzed the data: EF PB PM IEB FMF JAS JM. Wrote the paper: EF PB GT PM JRW IEB BA FMF DL FTM JAS JM.